Zions Bancorporation’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Zions Bancorporation’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-133	Closed	-$6K	–	920
2015 Q3	$6K	Buy	+133	New	+$5.61K	﹤0.01%	595
2015 Q2	–	Sell	-133	Closed	-$5K	–	898
2015 Q1	$5K	Buy	+133	New	+$5.12K	﹤0.01%	676

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Zions Bancorporation's WX Position: Q4 2015 in Review

Zions Bancorporation sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 133 shares — an estimated $6K sold.

Zions Bancorporation first reported a position in WX in Q1 2015 and held it in 2 quarters. The position peaked at $6K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Zions Bancorporation reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Zions Bancorporation sold 133 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $6K.
Zions Bancorporation first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2015 and held it in 2 quarters.
Zions Bancorporation's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $6K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Zions Bancorporation's 13F filing for Q4 2015, filed 16 Feb 2016.